Nursing Home Antibiotic Use Linked to High Rate of Problems: Study

|

Antibiotics are frequently prescribed to many nursing home residents. However, new research suggests that the drugs may be contributing to potentially serious health problems, including gastroenteritis, Clostridium difficile and antibiotic resistant bacteria. 

Researchers from the University of Toronto found one in eight nursing home residents experienced an adverse event related to antibiotic use, regardless of whether they were taking the antibiotics themselves. The findings were published June 29, in the journal JAMA Internal Medicine.

The longitudinal open-cohort study focused on more than 110,000 older adults in 607 different nursing homes in Ontario, Canada, between January 1, 2010, through December 31, 2011.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Researchers found that six percent to 10% of nursing home residents are taking antibiotics at any given time and more than half of them receive at least one antibiotic prescription each year.

Nursing home residents in the highest third of antibiotic use facilities had a 24% higher risk of having antibiotic related adverse events compared to those in the lower two-thirds of the facilities.

Antibiotic related adverse events were found to be more common in residents of high use homes at 13.3%, than among residents of medium use at 12.4% or low use homes 11.4%. The overuse contributes to adverse events, including contributing to the development of superbugs.

Overall researchers found residents were on antibiotics for an average of 20 to 192 days per 1,000 resident days.

Researchers found that high-use nursing homes were linked to an increased risk of residents experiencing antibiotic related adverse events, even residents who did not receive antibiotic treatments experience events.

Antibiotic-related adverse events included Clostridium difficile (C. diff), diarrhea, gastroenteritis, allergic reactions, general medication adverse events and antibiotic-resistant bacteria or superbugs.

The C. diff findings appear to confirm a study published in February, which revealed that the majority of the nearly half a million C. diff infections in the U.S. are hospital acquired infections among older patients taking antibiotics.

C. diff is the most common hospital-acquired infection in the U.S., striking particularly hard at patients ages 65 and older. The infections can cause fatal cases of colon inflammation and diarrhea.

“Residents of high-use homes are exposed to an increased risk of antibiotic-related harms even if they have not directly received these agents,” wrote study authors. “Antibiotic stewardship is needed to improve the safety of all nursing home residents.”

The study comes amid increasing concerns over antibiotic use.

A British Government report released last year warned there would be 10 million deaths each year by 2050 attributable to antibiotic resistant infections unless steps are taken to mitigate the growing risks posed by the overuse of antibiotic drugs.

Earlier this year, drug-resistant superbugs recently made headlines across the country after nearly 200 patients treated at California’s UCLA Medical Center were exposed to a deadly antibiotic-resistant bacteria. The outbreak caused two deaths, seven confirmed infections and was linked to tainted medical equipment, which had undergone normal sterilization treatment.

The U.S. Centers for Disease Control and Prevention (CDC) estimates drug-resistant bacteria, or superbugs, cause 2 million illnesses and approximately 23,000 deaths each year in the United States alone.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths.
Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks.
A federal judge will hold a hearing on Thursday with hair relaxer lawsuit parties in order to update the court on the status of the ongoing litigation.